| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −1.1× | −1.8× | |
| Price / Book | 1.1× | 2.1× | |
| Price / Sales | 93.0× | 4.0× | |
| Price / Free cash flow | −1.5× | −1.6× | |
| EV / EBITDA | −0.1× | −1.2× | |
| Earnings yield | −90.1% | −14.0% | |
| Free cash flow yield | −66.7% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,281.09 | −1.96% | $1.21T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.07 | −1.70% | $633.29B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $285.09 | −0.04% | $503.79B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $424.46 | −0.12% | $380.99B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.68 | −1.74% | $356.95B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.82 | −2.21% | $275.38B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $170.88 | −0.98% | $265.02B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $668.92 | −1.13% | $247.33B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $443.31 | −0.89% | $239.67B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.76 | −0.27% | $194.38B | 22.9× | 37.5% | +26.7% |
